Cisplatin
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category | Others |
Catalog number | BBF-03995 |
CAS | 15663-27-1 |
Molecular Weight | 300.05 |
Molecular Formula | Cl2H6N2Pt |
Purity | >98% |
Catalog Number | Size | Price | Stock | Quantity |
---|---|---|---|---|
BBF-03995 | 2 g | $269 | In stock |
Online Inquiry
Add to cartCapabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Cisplatin induces cytotoxicity by interaction with DNA to form DNA adducts which activate several signal transduction pathways, including Erk, p53, p73, and MAPK, which culminates in the activation of apoptosis. It is used in several types of cancer.
- Specification
- Properties
- Toxicity
- Reference Reading
- Spectrum
- Price Product List
- QC Data
Synonyms | (SP-4-2)-diamminedichloro-platinum |
Storage | Store at RT |
IUPAC Name | azanide;dichloroplatinum(2+) |
Canonical SMILES | [Cl-][Pt+2]([Cl-])([NH3])[NH3] |
InChI | InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2 |
InChI Key | LXZZYRPGZAFOLE-UHFFFAOYSA-L |
Appearance | Orange to Yellow Powder |
Application | Antineoplastic agent |
Melting Point | 270°C |
LogP | -2.19 |
Carcinogenicity | 2A, probably carcinogenic to humans. |
Mechanism Of Toxicity | Cisplatin is classified as an alkylating agent. Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations. |
Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive

Experimental Conditions
Ionization Energy: 70 eV
Chromatography Type: Gas Chromatography Column (GC)
Instrument Type: Single quadrupole, spectrum predicted by CFM-ID(EI)
Mass Resolution: 0.0001 Da
Molecular Formula: Cl2H4N2Pt
Molecular Weight (Monoisotopic Mass): 296.9399 Da
Molecular Weight (Avergae Mass): 298.035 Da
Predicted LC-MS/MS Spectrum - 10V, Positive

Experimental Conditions
Collision Energy: 10 eV
Instrument Type: QTOF (generic), spectrum predicted by CFM-ID
Mass Resolution: 0.0001 Da
Molecular Formula: Cl2H4N2Pt
Molecular Weight (Monoisotopic Mass): 296.9399 Da
Molecular Weight (Avergae Mass): 298.035 Da
BBF-00693 | Ansamitocin P-3 | Inquiry |
BBF-02582 | Polyporenic acid C | Inquiry |
BBF-01210 | Emericid | Inquiry |
BBF-02594 | Pyrrolnitrin | Inquiry |
BBF-00586 | Brefeldin A | Inquiry |
BBF-04621 | Artemisinin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
